ENIt almost always starts with painless blood in the urine, then a cystoscopy, a camera check of the bladder, after which the patient hears two scenarios that are easy to confuse at first: “we will take the tumour out through the water pipe” and “the bladder will have to come out”. These are two quite different kinds of bladder cancer surgery in Germany.
This page explains how they differ, what decides the choice, how urine is diverted in Germany after bladder removal and what life looks like afterwards; for the wider picture, see bladder cancer treatment in Germany.
What decides the choice of operation
It depends above all on whether the tumour has grown into the muscle layer of the bladder wall. The wall is layered: lining on the urine side, muscle deeper down. While the tumour stays in the top layer, the bladder is kept; once it enters the muscle (muscle-invasive cancer), removal is discussed.
Finding out takes a cystoscopy with biopsy, a pathology report with the grade, CT or MRI for spread and sometimes a second look through the urethra a few weeks later; see bladder cancer diagnostics.
A tumour board of several specialists sets the plan. With a muscle-invasive tumour, drug treatment before surgery is almost always discussed in Germany, which changes the order of events, as the German guideline on bladder cancer (in German) sets out. A second opinion matters too: a German pathologist’s review of the slides sometimes moves a case from one group to another.
Removing the tumour through the urethra
The operation is called transurethral resection, or TUR: an instrument passes through the urethra, with no cuts on the abdomen, and the tumour is shaved off and sent to the pathologist. It is both treatment and the main way to learn how deep the tumour has grown.
Afterwards the bladder is irrigated and a catheter stays in briefly. A chemotherapy drug is often instilled into the bladder once, soon after TUR, to reduce recurrence; high-risk tumours get a course of BCG, weakened tuberculosis-vaccine bacteria that trigger a local immune response (see immunotherapy for bladder cancer).
Superficial tumours tend to come back, so a TUR is always followed by a schedule of check-up cystoscopies that the patient takes home. With repeated recurrences, the question of removing the bladder returns.
Removing the bladder: when and how
The bladder is removed when the tumour has reached the muscle or a high-risk superficial tumour keeps returning. This is radical cystectomy: the bladder is taken out, in men with the prostate, in women with part of the neighbouring organs, plus the pelvic lymph nodes. It is major surgery with a real risk of complications.
In Germany it is done open or robotically through small openings. Robotic cystectomy belongs to the profile of certified uro-oncology centres; at University Hospital Essen, for example, such a centre is headed by Prof. Boris Hadaschik. At Munich Hospital Bogenhausen the uro-oncology and prostate cancer centres are led by PD Dr Atiqullah Aziz, whose field is robot-assisted surgery for urological cancers, including radical cystectomy.
Pelvic lymph nodes are removed on both sides; how widely is discussed separately, as there is no agreed boundary and wider removal stages the disease better but lengthens surgery. Cystectomy belongs in centres that do many, as they have fewer complications. Nerve sparing, which can help preserve sexual function and continence, is discussed case by case; the surgeon, not the patient’s wish, decides if it is possible.
Where the urine goes afterwards
With the bladder gone, the urine has to be led somewhere else, and there is more than one solution.
The two main options are a neobladder, a new bladder built from bowel and joined to the urethra, so urine is passed the usual way, and diversion through an opening in the abdominal wall into a stoma bag. Separately, there is a reservoir emptied by catheter through a small skin opening. These operations are done, for example, at the Urology Clinic Munich-Planegg, which lists radical cystectomy with urinary diversion, including neobladder and reservoir, among its fields.
The choice depends on whether the urethra is tumour-free and the kidneys work well, where exactly the tumour sat, age, and the ability to self-catheterise or care for a stoma. Continence after a neobladder comes gradually and needs training; night-time dryness takes longer.
After the operation: recovery and follow-up
Recovery starts at once: getting up on the first day, breathing exercises, a gradual return to normal food and thrombosis prevention. A few days later the pathology report on the bladder and lymph nodes arrives and decides whether drug treatment follows.
Then come neobladder or stoma training, pelvic floor exercises, regular kidney and metabolic checks and a schedule of CT scans and other tests. The cost of bladder cancer treatment page explains what the post-operative calculation includes.
Frequently asked questions
Is the whole bladder always removed in bladder cancer?
No. If the tumour has not reached the muscle layer, it is removed through the urethra and the bladder is kept, followed by drug instillations and check-up cystoscopies. Removal is discussed when the tumour has entered the muscle or a high-risk superficial tumour keeps returning.
Can you live without a bladder?
Yes. The urine takes a new route: into a neobladder made from bowel, through a stoma into a bag, or into a reservoir emptied with a catheter. Each option takes getting used to — stoma care, catheterising or continence training. This is taught in hospital, and regular check-ups follow.
Is robotic cystectomy available in Germany?
Yes, alongside open surgery: the robot works through small openings, controlled by the surgeon from a console. The German guideline allows both approaches, and the surgeon decides which suits after the tests. Either way, much depends on the surgeon’s experience and how often the centre does such operations.
How AlenMed arranges the operation
AlenMed sends the documents — cystoscopy report, histology with slides, CT or MRI, lab results, discharge letters — to the uro-oncology centre, which answers whether drug treatment before surgery is under discussion, which urinary diversion is realistic here and whether more tests are needed on site. Then come a written estimate, a visa invitation, appointments and surgery booked back to back, and an interpreter at consultations and ward rounds.
Plan for a companion, a stay long enough for stoma or neobladder training, and a translation of the operation report and follow-up plan for your doctor at home.
This material is for information only and is not an offer; the type of operation and urinary diversion are decided by a doctor in person.
News on this topic
Charité treats first beta-thalassemia patient with CRISPR
At Berlin Charité, a 19-year-old beta-thalassemia patient became the first in Germany to receive the newly approved CRISPR gene therapy Exagamglogene Autotemcel.
Real-World Breast Cancer Study Confirms High Five-Year Survival Rates in Germany
A landmark study of over 43,000 German patients reveals a five-year invasive disease-free survival rate of 82.9 percent in early hormone receptor-positive breast cancer.
FDA Approves Jülich Diagnostic Radiotracer FET for Brain Tumor Imaging
The FDA approves the diagnostic radiotracer FET (Pixclara®) for evaluating brain gliomas, highlighting decades of neuro-oncology research at Forschungszentrum Jülich.
